Position in ALMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,783,538
-$40,515,136 QoQ
Shares Held
951,796
-68.8% QoQ
Ownership
0.735%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 198 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ALMS ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ALMS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,783,538 | 951,796 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $67,298,674 | 3,054,865 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,112,609 | 113,997 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,043,073 | 762,675 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,622,665 | 1,207,555 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $590,225 | 96,128 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $378,207 | 48,118 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $81,210 | 7,604 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||